• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session

    9/7/22 12:22:21 PM ET
    $ALNA
    $AQST
    $ASO
    $AVCT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALNA alert in real time by email

    Gainers

    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares surged 44.3% to $4.7893 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target.
    • IMARA Inc. (NASDAQ:IMRA) rose 37% to $1.57 after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront.
    • Sidus Space, Inc. (NASDAQ:SIDU) gained 26.7% to $3.3701 after the company announced that it has signed a launch agreement with SpaceX for five launches, beginning in early 2023.
    • Cryo-Cell International, Inc. (NYSE:CCEL) jumped 17.7% to $7.86.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 19.7% to $6.45 after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.
    • Azure Power Global Limited (NYSE:AZRE) shares gained 17.3% to $4.21. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) jumped 17.3% to $0.8565.
    • Glaukos Corporation (NYSE:GKOS) gained 17.3% to $56.40 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety profile through 12 months.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) rose 16.8% to $1.4599. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
    • Spero Therapeutics, Inc. (NASDAQ:SPRO) shares rose 16.4% to $1.3150. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
    • Biophytis S.A. (NASDAQ:BPTS) shares gained 16% to $1.0899 after the company released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure.
    • SelectQuote, Inc. (NYSE:SLQT) rose 15.4% to $1.2808.
    • Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 14.2% to $6.16. Seres Therapeutics announced completion of rolling BLA submission to the FDA for investigational microbiome therapeutic SER-109 for recurrent C. Difficile infection.
    • Academy Sports and Outdoors, Inc. (NASDAQ:ASO) jumped 12% to $46.98. Academy Sports And Outdoors reported a second-quarter FY22 sales decline of 5.8% year-on-year to $1.69 billion.
    • Nutex Health, Inc. (NASDAQ:NUTX) jumped 11.5% to $2.90.
    • Unico American Corporation (NASDAQ:UNAM) gained 10.6% to $1.8580.
    • Coupa Software Incorporated (NASDAQ:COUP) rose 10.5% to $61.65 as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
    • Tempur Sealy International, Inc. (NYSE:TPX) jumped 8.2% to $26.39.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 7.6% to $9.47.
    • Baudax Bio, Inc. (NASDAQ:BXRX) rose 7.6% to $0.3243 after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.


    Losers

    • Great Panther Mining Limited (NYSE:GPL) dropped 65% to $0.2801. Great Panther recently announced it will file a notice of intention to make a proposal under the Bankruptcy and Insolvency Act (Canada).
    • CleanTech Acquisition Corp. (NASDAQ:CLAQ) shares fell 36.4% to $6.03 after the company reported shareholder voting results in 8K filing.
    • NewAge, Inc. (NASDAQ:NBEV) shares dipped 25% to $0.0937 after dipping over 15% on Tuesday. The company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) fell 22.8% to $1.96.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares dipped 20.6% to $3.35 after jumping around 33% on Tuesday. First Wave BioPharma recently announced a 1:30 reverse stock split.
    • Presidio Property Trust, Inc. (NASDAQ:SQFT) fell 18.3% to $1.7001. Presidio Property Trust recently declared Q3 dividend and adopted variable dividend policy.
    • Golden Path Acquisition Corporation (NASDAQ:GPCO) dropped 17.5% to $8.46.
    • AMTD Digital Inc. (NYSE:HKD) dropped 16.4% to $57.63.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) declined 16.3% to $0.1842. American Virtual Cloud Technologies recently announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
    • UiPath Inc. (NYSE:PATH) fell 13.9% to $13.43 after the company issued Q3 and FY23 sales guidance below analyst estimates.
    • John Wiley & Sons, Inc. (NYSE:WLY) dropped 13.6% to $39.81 after the company reported worse-than-expected Q1 EPS and sales results.
    • Veru Inc. (NASDAQ:VERU) declined 13.5% to $12.62. Traders circulate word FDA decision on the company’s COVID treatment coming on Oct. 6.
    • FaZe Holdings Inc. (NASDAQ:FAZE) dipped 12.1% to $12.06.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) dropped 11% to $2.4289.
    • Vacasa, Inc. (NASDAQ:VCSA) fell 9.5% to $3.6450.
    • DBV Technologies S.A. (NASDAQ:DBVT) fell 8.5% to $2.15 after gaining around 8% on Tuesday. DBV Technologies, last month, posted a Q2 loss of $0.35 per share.
    • Korn Ferry (NYSE:KFY) fell 8.2% to $55.26 following downbeat quarterly earnings.
    • G-III Apparel Group, Ltd. (NASDAQ:GIII) dropped 5.6% to $18.73 after the company posted downbeat quarterly earnings and lowered FY23 forecast.
    • GameStop Corp. (NYSE:GME) fell 4.5% to $24.00 ahead of quarterly earnings.
    Get the next $ALNA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNA
    $AQST
    $ASO
    $AVCT

    CompanyDatePrice TargetRatingAnalyst
    Aquestive Therapeutics Inc.
    $AQST
    4/24/2026$8.00Outperform
    Oppenheimer
    G-III Apparel Group LTD.
    $GIII
    3/13/2026$34.00 → $29.00Market Perform
    Telsey Advisory Group
    UiPath Inc.
    $PATH
    3/12/2026$15.00Hold → Buy
    Needham
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    DBV Technologies S.A.
    $DBVT
    12/15/2025$42.00Overweight
    Cantor Fitzgerald
    G-III Apparel Group LTD.
    $GIII
    12/10/2025$30.00 → $34.00Market Perform
    Telsey Advisory Group
    DBV Technologies S.A.
    $DBVT
    12/3/2025$35.00Buy
    Guggenheim
    Glaukos Corporation
    $GKOS
    10/27/2025$120.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $ALNA
    $AQST
    $ASO
    $AVCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. FundTickerDistribution Per ShareDistribution Rate30-Day SEC YieldReturn of CapitalEx-Date / Record DatePayment Date1-Month Return1-Year ReturnSince InceptionReturn*Bitwise COINOption Income Strategy ETFICOI$0.2544725.40 %0.00 %100.00 %4/24/20264/28/2026-4.73 %-28.24 %-24.19 %Bitwise MARAOption Income Strategy ETFIMRA$0.1476311.25 %0.00 %100.00 %4/24/2

    4/23/26 5:06:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Sidus Space Advances its Fortis Next-Generation Command and Data Handling (C&DH) System

    Microchip collaboration enables accelerated, modular, and mission‑scalable OpenVPX architectures for space and defense applications CAPE CANAVERAL, Fla., April 23, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced continued advancements to its Fortis Command and Data Handling (C&DH) platform, a modular 3U OpenVPX system designed to support rapid development, configuration flexibility, and long-term scalability across next-generation space and defense missions. Supported by a strate

    4/23/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

    HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the first fiscal quarter ended March 31, 2026, on Thursday, April 30, 2026 after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a b

    4/22/26 4:15:00 PM ET
    $NUTX
    Real Estate

    $ALNA
    $AQST
    $ASO
    $AVCT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IDOSE TR issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug IDOSE TR (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/15/23 11:41:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    FDA Approval for TRAVOPROST issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug TRAVOPROST (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/14/23 7:41:03 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $ALNA
    $AQST
    $ASO
    $AVCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    PRESIDENT Grant Robert Clay bought $105,024 worth of shares (118,901 units at $0.88) (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    2/19/26 4:11:41 PM ET
    $SLQT
    Specialty Insurers
    Finance

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ALNA
    $AQST
    $ASO
    $AVCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oppenheimer resumed coverage on Aquestive Therapeutics with a new price target

    Oppenheimer resumed coverage of Aquestive Therapeutics with a rating of Outperform and set a new price target of $8.00

    4/24/26 8:31:20 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Telsey Advisory Group reiterated coverage on G-III Apparel with a new price target

    Telsey Advisory Group reiterated coverage of G-III Apparel with a rating of Market Perform and set a new price target of $29.00 from $34.00 previously

    3/13/26 8:22:27 AM ET
    $GIII
    Apparel
    Consumer Discretionary

    UiPath upgraded by Needham with a new price target

    Needham upgraded UiPath from Hold to Buy and set a new price target of $15.00

    3/12/26 8:42:03 AM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    $ALNA
    $AQST
    $ASO
    $AVCT
    SEC Filings

    View All

    Mobile Global Esports Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Mobile Global Esports, Inc. (0001886362) (Filer)

    4/23/26 9:23:24 PM ET
    $MGAM
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Nutex Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Nutex Health Inc. (0001479681) (Filer)

    4/23/26 4:05:58 PM ET
    $NUTX
    Real Estate

    SEC Form DEFA14A filed by Presidio Property Trust Inc.

    DEFA14A - Presidio Property Trust, Inc. (0001080657) (Filer)

    4/21/26 5:07:03 PM ET
    $SQFT
    Real Estate Investment Trusts
    Real Estate

    $ALNA
    $AQST
    $ASO
    $AVCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tweedy Jeffrey C.

    4 - Academy Sports & Outdoors, Inc. (0001817358) (Issuer)

    4/17/26 8:59:24 AM ET
    $ASO
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Lee Philina

    3 - DBV Technologies S.A. (0001613780) (Issuer)

    4/16/26 4:51:42 PM ET
    $DBVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Robinson Mark Haymond

    4 - GameStop Corp. (0001326380) (Issuer)

    4/15/26 6:45:04 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ALNA
    $AQST
    $ASO
    $AVCT
    Leadership Updates

    Live Leadership Updates

    View All

    DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

    Châtillon, France, March 24, 2026 DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Changes went into effect on Monday, March 23, 2026 DBV Technologies (TRQX:DBVp), a late-stage biopharmaceutical company, today announced that following the annual review of the Euronext Paris indices on March 12, 2026, the Scientific Council of the Indices has admitted DBV to the CAC Mid 60 and SBF 120 Indices. The changes went into effect on Monday, March 23, 2026. "We are proud to be admitted into the CAC Mid 60 and SBF 120 Indices, which reflect the financial markets' recognition of our continued progress," stated Daniel Tassé, Chief Executive Officer of D

    3/24/26 4:30:00 PM ET
    $DBVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

    Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026Lori J. Braender to remain in a non-executive role as Corporate Secretary after nearly eight years as Chief Legal Officer, Chief Compliance Officer and Corporate Secretary WARREN, N.J., March 20, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer, effective Apr

    3/20/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

    Readout of investigator-sponsored SER-155 study in immune checkpoint–related enterocolitis, a frequent and serious side effect in cancer patients treated with immune checkpoint inhibitors, on track for Q2 2026  Seres operational focus on advancing live biotherapeutic programs for inflammatory and immune diseases Company working to create meaningful partnerships with collaborators to support continued development of pipeline programs, including SER-155 for allogeneic hematopoietic stem cell transplant (allo-HSCT)  CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), (Seres or the Company), a leading live biotherapeutics company, today reported fou

    3/12/26 7:00:00 AM ET
    $MCRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNA
    $AQST
    $ASO
    $AVCT
    Financials

    Live finance-specific insights

    View All

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. FundTickerDistribution Per ShareDistribution Rate30-Day SEC YieldReturn of CapitalEx-Date / Record DatePayment Date1-Month Return1-Year ReturnSince InceptionReturn*Bitwise COINOption Income Strategy ETFICOI$0.2544725.40 %0.00 %100.00 %4/24/20264/28/2026-4.73 %-28.24 %-24.19 %Bitwise MARAOption Income Strategy ETFIMRA$0.1476311.25 %0.00 %100.00 %4/24/2

    4/23/26 5:06:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

    HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the first fiscal quarter ended March 31, 2026, on Thursday, April 30, 2026 after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a b

    4/22/26 4:15:00 PM ET
    $NUTX
    Real Estate

    NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 21, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on April 21stThe major averages are climbing Tuesday morning as investors react to the latest developments in Iran and fresh earnings.UiPath (NYSE:PATH) CMO Michael Atalla will join NYSE Live to discuss his company's five-year anniversary as a listed company.HSBC (NYSE:HSBC) Innovation Banking Managing Director Jonathan Norris

    4/21/26 8:55:00 AM ET
    $HSBC
    $ICE
    $PATH
    Savings Institutions
    Finance
    Investment Bankers/Brokers/Service
    Computer Software: Prepackaged Software

    $ALNA
    $AQST
    $ASO
    $AVCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AMTD Digital Inc.

    SC 13G/A - AMTD Digital Inc. (0001809691) (Subject)

    11/14/24 9:33:22 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    11/14/24 7:31:47 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Quoin Pharmaceuticals Ltd.

    SC 13G/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Subject)

    11/14/24 7:23:29 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care